← Evidence map

ArticlePloS one2026

Real-world implementation and cost impact analysis of Oncotype DX testing in early-stage breast cancer.

Niina Mäenpää et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42461910